1. Fine PEM, Carneiro IAM, Milstien JB, Clements CJ, World Health O. Issues relating to the use of BCG in immunization programmes: a discussion document. Geneva: World Health Organization; 1999. Available at: https://apps.who.int/iris/handle/10665/66120
2. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994;271(9):698-702. https://doi.org/10.1001/jama.1994.03510330076038 PMID:8309034
3. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995;346(8986):1339-45. https://doi.org/10.1016/s0140-6736(95)92348-9 PMID:7475776
4. Salmon C, Conus F, Parent M-É, Benedetti A, Rousseau M-C. Association between Bacillus Calmette-Guerin (BCG) vaccination and lymphoma risk: A systematic review and meta-analysis. Cancer Epidemiology. 2020;65:101696. https://doi.org/10.1016/j.canep.2020.101696
5. Houghton BB, Chalasani V, Hayne D, Grimison P, Brown CSB, Patel MI, et al. Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis. BJU International. 2013;111(6):977-83. https://doi.org/10.1111/j.1464-410X.2012.11390.x PMID:23253618